Consistently, genetic reduction of tau accumulation occurring in Retinal Ganglion Cells (RGC) and optical nerves of 3-month-old 3xTg-AD mice significantly improves cell density and functionality [63]. The gene discussed is MAPT; the disease is Alzheimer disease.